SBALO National Oncology Center
About SBALO National Oncology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Central European Cooperative Oncology Group
5
European Organisation for Research and Treatment of Cancer - EORTC
2
Clinical Trials at SBALO National Oncology Center
During the past decade, SBALO National Oncology Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
1,000
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
2000-06-01
Unknown status
1,258
Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
2005-07-01
2007-10-01
Completed
150
Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
2004-03-01
2008-07-01
Completed
125
Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
2002-06-01
2005-10-01
Completed
430
ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
2003-12-01
2007-11-01
Terminated
376
Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer
2008-01-01
2015-11-01
Completed
151
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SBALO National Oncology Center
According to Clinical.Site data, the most researched conditions in "SBALO National Oncology Center" are
"Melanoma (Skin)" (2 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Gastrointestinal Stromal Tumors" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "SBALO National Oncology Center" in a lesser frequency.
Clinical Trials Intervention Types at SBALO National Oncology Center
Most popular intervention types in "SBALO National Oncology Center" are "Drug" (5 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan" (1 trials), "Docetaxel" (1 trials), "FOLFIRI" (1 trials), "FOLFOX 6" (1 trials) and "FOLFOX4 (Oxaliplatin), Cetuximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SBALO National Oncology Center
The vast majority of trials in "SBALO National Oncology Center" are
5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at SBALO National Oncology Center
Currently, there are NaN active trials in "SBALO National Oncology Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in SBALO National Oncology Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in SBALO National Oncology Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of SBALO National Oncology Center
SBALO National Oncology Center has several departments that took part in Clinical trials: "Spetsializirana Bolnitsa za Aktivno Lechenie po Onkologiya, Klinika po himioterapiya" - 2 trials
Departments List